Connection

Andrea Antinori to Compassionate Use Trials

Back to Details
This is a "connection" page, showing publications Andrea Antinori has written about Compassionate Use Trials.
Andrea Antinori
Connection Strength
0.030
Compassionate Use Trials
  1. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study. Lancet Gastroenterol Hepatol. 2017 06; 2(6):427-434.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.